BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28065618)

  • 1. Pathological features and clinical behavior of Lynch syndrome-associated ovarian cancer.
    Ryan NAJ; Evans DG; Green K; Crosbie EJ
    Gynecol Oncol; 2017 Mar; 144(3):491-495. PubMed ID: 28065618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.
    Chui MH; Ryan P; Radigan J; Ferguson SE; Pollett A; Aronson M; Semotiuk K; Holter S; Sy K; Kwon JS; Soma A; Singh N; Gallinger S; Shaw P; Arseneau J; Foulkes WD; Gilks CB; Clarke BA
    Am J Surg Pathol; 2014 Sep; 38(9):1173-81. PubMed ID: 25025451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gynecological surveillance of women with Lynch syndrome in Sweden.
    Tzortzatos G; Andersson E; Soller M; Askmalm MS; Zagoras T; Georgii-Hemming P; Lindblom A; Tham E; Mints M
    Gynecol Oncol; 2015 Sep; 138(3):717-22. PubMed ID: 26177554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies.
    Ryan NAJ; Morris J; Green K; Lalloo F; Woodward ER; Hill J; Crosbie EJ; Evans DG
    JAMA Oncol; 2017 Dec; 3(12):1702-1706. PubMed ID: 28772289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian cancer in Lynch syndrome; a systematic review.
    Helder-Woolderink JM; Blok EA; Vasen HF; Hollema H; Mourits MJ; De Bock GH
    Eur J Cancer; 2016 Mar; 55():65-73. PubMed ID: 26773421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic characteristics and outcomes of endometrial Cancer patients with mismatch repair deficiency in the era of universal Lynch syndrome screening.
    Carr C; Son J; Yao M; Priyadarshini A; Marquard J; Vargas R; Michener C; AlHilli MM
    Gynecol Oncol; 2020 Dec; 159(3):712-720. PubMed ID: 33046272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Lynch syndrome associated ovarian cancer.
    Woolderink JM; De Bock GH; de Hullu JA; Hollema H; Zweemer RP; Slangen BFM; Gaarenstroom KN; van Beurden M; van Doorn HC; Sijmons RH; Vasen HFA; Mourits MJE
    Gynecol Oncol; 2018 Aug; 150(2):324-330. PubMed ID: 29880284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct molecular profiles in Lynch syndrome-associated and sporadic ovarian carcinomas.
    Niskakoski A; Kaur S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
    Int J Cancer; 2013 Dec; 133(11):2596-608. PubMed ID: 23716351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
    Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
    Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lynch syndrome screening in gynaecological cancers: results of an international survey with recommendations for uniform reporting terminology for mismatch repair immunohistochemistry results.
    Ryan N; Wall J; Crosbie EJ; Arends M; Bosse T; Arif S; Faruqi A; Frayling I; Ganesan R; Hock YL; McMahon R; Manchanda R; McCluggage WG; Mukonoweshuro P; van Schalkwyk G; Side L; Smith JH; Tanchel B; Evans DG; Gilks CB; Singh N
    Histopathology; 2019 Dec; 75(6):813-824. PubMed ID: 31310679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Lynch syndrome in women with mismatch repair-deficient ovarian cancer.
    Hodan R; Kingham K; Cotter K; Folkins AK; Kurian AW; Ford JM; Longacre T
    Cancer Med; 2021 Feb; 10(3):1012-1017. PubMed ID: 33369189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converging endometrial and ovarian tumorigenesis in Lynch syndrome: Shared origin of synchronous carcinomas.
    Niskakoski A; Pasanen A; Porkka N; Eldfors S; Lassus H; Renkonen-Sinisalo L; Kaur S; Mecklin JP; Bützow R; Peltomäki P
    Gynecol Oncol; 2018 Jul; 150(1):92-98. PubMed ID: 29716739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicalpathological characteristics of Lynch syndrome related epithelial ovarian cancer].
    Ma XG; Wang YM; Xue FX; Zhang HY; Sheng HN; Qi Z; Liu GY
    Zhonghua Fu Chan Ke Za Zhi; 2012 Mar; 47(3):201-4. PubMed ID: 22781072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant frequency of MSH2/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas.
    Rambau PF; Duggan MA; Ghatage P; Warfa K; Steed H; Perrier R; Kelemen LE; Köbel M
    Histopathology; 2016 Aug; 69(2):288-97. PubMed ID: 26799366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synchronous Endometrial and Ovarian Cancer in Young Women: Case Report and Review of the Literature.
    Dogan A; Schultheis B; Rezniczek GA; Hilal Z; Cetin C; Häusler G; Tempfer CB
    Anticancer Res; 2017 Mar; 37(3):969-978. PubMed ID: 28314254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer.
    Mills AM; Liou S; Ford JM; Berek JS; Pai RK; Longacre TA
    Am J Surg Pathol; 2014 Nov; 38(11):1501-9. PubMed ID: 25229768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The results of gynecologic surveillance in families with hereditary nonpolyposis colorectal cancer.
    Ketabi Z; Gerdes AM; Mosgaard B; Ladelund S; Bernstein I
    Gynecol Oncol; 2014 Jun; 133(3):526-30. PubMed ID: 24631699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
    Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
    J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PMS2 germline mutation c.943C>T (p.Arg315*)-induced Lynch syndrome-associated ovarian cancer.
    Guo X; Wu W; Gao H; Li X; He Q; Zhu Y; Liu N
    Mol Genet Genomic Med; 2019 Jun; 7(6):e721. PubMed ID: 31056861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying Lynch syndrome in patients with ovarian carcinoma: the significance of tumor subtype.
    Chui MH; Gilks CB; Cooper K; Clarke BA
    Adv Anat Pathol; 2013 Nov; 20(6):378-86. PubMed ID: 24113308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.